The Immune Reset: How Cancer’s "Living Drug" Is Rewriting the Future of Autoimmune Care
For decades, the standard of care for autoimmune diseases like multiple sclerosis (MS), lupus, and vasculitis has been defined by a strategy of management rather than resolution. Patients have relied…







